2010 may be the most incredible year in history for medical technology stocks. A handful of truly amazing technologies-in-development are likely to make headlines this coming year…and these headlines could produce huge gains in the share prices of selected medical technology companies…
[Read more...]
RNA Interference’s Hot Partnership With Stem Cells
Stem cell therapy and RNA interference (RNAi) may be the sexiest hook-up since peanut butter and chocolate. And scientists are just beginning to explore the potential of combining these medical therapies.
Until very recently, the application of each therapy seemed very specific and limited: stem cells for regenerative medicine; RNAi for genetic correction. Furthermore, the repairing abilities of stem cells seemed more limited than first expected, and RNAi proved very difficult to be delivered to its intended targets.
[Read more...]Click for detailed story